Sitagliptin phosphate

Details

Files

Generic Name:

Sitagliptin phosphate

Project Status:

Complete

Therapeutic Area:

Diabetes mellitus (Type 2)

Manufacturer:

Merck Frosst Canada Ltd.

Brand Name:

Januvia

Project Line:

Reimbursement Review

Project Number:

SR0122-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Diabetes mellitus (Type 2)

Recommendation Type:

Do not list

Final Recommendation:

June 18, 2008

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Summary of CEDAC Discussion View PDF

Overview of CDR Reports View PDF

Plain Language Recommendation View PDF

Last Updated : December 20, 2007